Get started

Pharmastocks

Auropharma - 800 - Darna Jaroor -Selling the Top Once Again !Good Morning All, Feel Excited to share the photo from future assignment of the Auro fall right at the top from my sessions. As suggested last in the update mentioned below, moving and holding above 780 - we expected targets of 785 -790 and 798 Let us check in order Last Idea Review Last update on the post as of 15th Nov 2018 Previous Idea Photo session before we leave Next Trading Strategy Last Idea Review Targets above 780 was achieved twice. 1st attempt -785- 792 -later closing the buy position close to 792 levels & in next attempt above 780 - 785-790 & 798 all achieved once again before it turns back from 800 levels again - Darna Jaroor --------------------------------------------------------------------------------------------------------------------------------- Last update on the post as of 15th Nov 2018 Trade active: 23:20 Hrs 15th Nov 2018 Last Price@780 Any move above 780 & holding 780 - Auro can have short term push upside to 785 -790 -798 levels Fall can and should continue only if Auro stays below 780 levels. Thanks and Good Night. ---------------------------------------------------------------------------------------------------------------------------------------- Previous Idea It's the time to disco - five turns to 785 ------------------------------------------------------------------------------------------------------------------------------------------ Photo session before we leave "Say Cheese" at the lunch session - Falling from 800 - 19th Nov 2018 12:26 Hrs IST --------------------------------------------------------------------------------------------------------------------------------------- Trading Strategy Break of Trendline - we shall look at 775 - below 773 next shall be 765 - 760 & below 760 -745 - in case of severe fall we can expect 730-735 zone Thanks
NSE:AUROPHARMAShort
by WaveTalks
2
Auropharma - It's the Time to Disco -Five Turns to 785Update Do check -Latest update in previous idea- "Playing with Channel" - taking current price action into consideration. ------------------------------------------------------------------------------------------------------------------ Chart Snapshot at 09:57 Hrs Last Price@789 ----------------------------------------------------------------------------------------------------------------- Let us run the flashback 13th Nov 2018 Auropharma screamed to me post falling to lows of 760’s that I will do disco dance tomorrow 14th Nov 2018 on account of children's day - suggesting me the range as well - 780 to 765 --------------------------------------------------------------------------------------------------------------------------------- As updated on the post – “Playing with the channel” @15:50 Hrs -13th Nov 2018 --------------------------------------------------------------------------------------------------------------------------------- Closing Price@775 Top of 780's was kissed in today's session against our expectation of 785 - 790 zone from bottoms of 760's Planning for Tomorrow -14th Nov 2018 Any chance to sell in 777- 780 zone shall be short term opportunity for 770- 765 targets downside Later Plan to buy in 760-765 zone if 759 is intact downside as It may do disco dance tomorrow between 780's to 760 zone Because it needs to spend some time so next we plan to sell at the top range close by 780's & buy at bottom of the range which 760's -and dance with the market. --------------------------------------------------------------------------------------------------------------------------- 14th Nov 2018 5 Turns to 785 which was updated on the post – “Playing with the channel” “If you missed the updates on the post – check your settings in idea stream tab in tool's panel.” -------------------------------------------------------------------------------------------------------------------------- 15th Nov 2018 Trading Strategy - Latest Update Taking into consideration early price action of today - 785 is key level and 790 is critical level -till the time 790 is intact -we shall sell for 775 -765 - 760 & below 760 for 745-748 target zone. Plan A Fall to continue from 785 – It’s 785 – Going Below 765 & Breaking 760’s can take stock to 745-748 zone which is next important support zone. Plan B In case, it holds 765 – does not move below 765 then risky buyers can take buy call /long position with strict stop loss below 765 & upside target as 773-778 later. -------------------------------------------------------------------------------------------------------------------------------------- Hope, you enjoyed the disco dance – 5 Turns to 785. Do take good care of yourself. Thanks for watching the video and your precious time.
NSE:AUROPHARMAShort
by WaveTalks
2
Auropharma - Playing with the channel- Below 808Auropharma - Playing with the channel Excited to come up with the video. Let us enjoy the market together. Do let me know your comments. Do take good care of yourself. 11:30 Hrs - 12th Nov 2018 Last Price@812.30 Trading Strategy Downside Target - 790-794 zone below 808 Going below 790 - Look for 785 -780's target and take rest. Missed the last update - do check in the profile page or mentioned below Last Video Update -Price is immortal
NSE:AUROPHARMAShort
by WaveTalks
25
Flag Breakout Trend Reversal Case: The stock was in downtrend through out the bull run of Nifty it made only lower lows. It is trading above the trend line and seems to have reversing the trend. It has made a Flag pattern and closed above its boundary today. One can trade the stock now for a target of around 1000. Those interested in investing for medium/long term can also consider to have it for their portfolio. Disclaimer : All ideas are my personnel view. Please take financial consultancy for trading decision.
NSE:LUPINLong
by praveen.bhatiya
3
My Predictive Engine's Intraday call - SunPharma - ShortOff-late I started investigating more on predicting the next candle for the day and seeing enough success by using the patterns of various indicators. Pine scripting in tradingview has helped a lot to automate everything and create necessary signals. Based on the engine's call, tomorrow (22-Mar-2018) will be a super "Red" candle for NSE:SUNPHARMA . Following are the entry/exit points Short Below: 503.0 Target-1: 499.5 Target-2: 497.2 Target-3: 494.8 Stop loss: 508.2 Happy trading
NSE:SUNPHARMAShort
by MuthiahM
Aurobindo: Will This Pill End The Pain ?! contd..This is the continuation of my previous long term analysis on Aurobindo As expected Aurobindo took nice support at 580 and rebound sharply upto the falling trendline of the downward sloping channel. Volume-Spread: As expected stock seems facing resistance near 620-630 levels. The volume however is declining. Stock had a huge volume at 'a' but long wick at the top says supply is there at 607. As this resistance level is crossed at 'b' we dun see a spike in volume, suggesting declining demand. A new high at 'c' but further declining volume, even less demand. New high at 'd', price juuuust crossed falling trendline with rise in volume but doji bar says indecision. So may be some profit booking started. Notice that the price declined thereafter that but volume is not picking up, it suggests that bulls are still holding and bears are not still active. Currently it is trying to build a support near 598 level. Although these are signs of consolidate near resistance yet I would say that, as mentioned in my earlier post, 580 is a key level to watch out for. Holding or breaking this support may decide the near term future of this stock. This is just an analysis and not an investment advice. I always respect if you have your own different opinion on the stock. Thanks Like, comment, share and follow.
NSE:AUROPHARMA
by Bravetotrade
4
LUPIN BUY (LONG)Lupin is a BUY at CMP@1470 with SL@1420 for a target of TP@1600 Lupin gets USFDA nod to market pain relief, colonoscopy drugs and also gets FDA approval for generic Percocet tablets . Lupin recently received FDA approval for generic Suprep Bowel Prep Kit and Suprep kit approval It may add 5% to Lupin’s EPS for FY18 earnings. In addition the pharma major’s Goa facility has been cleared by the US FDA. Lupin Result: Revenue grew 26% YoY to INR 44.8b Gross margin was stable QoQ at 71.0%. EBITDA rose 27% YoY to INR 12.2b with margin of 27% . EBITDA margin improvement was primarily driven by strong growth in US sales (+53% YoY, +8% QoQ; despite R&D as % of sales at 12.9%) and forex gain of INR 270m. PAT of INR 6.3b was impacted by 1% due to a high tax rate of 39%. Lupin is a BUY at CMP@1470 with SL@1420 for a target of TP@1600
NSE:LUPINLong
by VIRUSSOUL